Not sure what is going on ... The company is doing well and just announced positive news as of late (with the new chairman of the medical advisory board and the new partnership for production in Denver). Well, at least this poses as a load-up opportunity.
Realistically I believe this may have to do with the warrants at .10 and .15 that can be converted until 2017. It gives me major headaches trying to make heads and tails of all the promissory notes and warrants that these types of companies accrue trying to raise money.
I am tapped out until next February. If the stock should still be under .20 at that time, I will be buying more.